OAOsamu Adachi

Osamu Adachi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Osamu Adachi has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • New Challenges That We Are Facing LVAD Therapy for End-stage at Heart Failure

    by Yoshikatsu Saiki, Ko Sakatsume, Masatoshi Akiyama, Satoshi Kawatsu, Ichiro Yoshioka, Yusuke Suzuki, Yukihiro Hayatsu, Osamu Adachi, Kiichiro Kumagai, Konosuke Sasaki, et al.

  • Comparison of Renal Function after Implantation of Continuous-flow and Pulsatile Left Ventricular Assist Devices

    by Masatoshi Akiyama, Satoshi Kawatsu, Ichiro Yoshioka, Osamu Adachi, Kiichiro Kumagai, Yoshikatsu Saiki

  • Hepatitis C Virus Positivity Negatively Affects Cardiac Functions and Long-term Prognosis in Patients with Adult Congenital Heart Disease

    by Ryo Konno, Shunsuke Tatebe, Koichiro Sugimura, Kimio Satoh, Tatsuo Aoki, Saori Yamamoto, Osamu Adachi, Masato Kimura, Yoshikatsu Saiki, Hiroaki Shimokawa

    • 1 May 2016
      • Vol. 69  (5) , 331-6

    [Issues in Coronary Artery Bypass Grafting for Kawasaki Disease].

    by Shintaro Katahira, Shunsuke Kawamoto, Katsuhiro Hosoyama, Naoki Masaki, Keisuke Kanda, Tomoyuki Suzuki, Satoshi Kawatsu, Ichiro Yoshioka, Hidenori Fujiwara, Kiichiro Kumagai, et al.

    Progressive narrowing at the entrance and exit of coronary artery aneurysm can develop at late phase of Kawasaki disease (KD). Evaluation and prediction of progressive coronary lesions remain a challenge in the treatment of post-KD coronary artery disease. We aimed to elucidate long-standing issues imposed on the patients who underwent coronary artry bypass grafting (CABG) for coronary artery lesions associated with KD. Between January, 2000 and December, 2013, CABG for coronary artery lesions associated with KD were performed in 6 patients (male/female: 5/1, mean age 14.5±10.0). There was no operative mortality. Follow-up for the 6 patients has been performed with the average period of 5 years (1~9 years). Cardiac events occurred in 2 patients during follow-up. In 1 patient, left internal thoracic artery (LITA) occluded due to flow competition between the native artery and LITA graft after LITA to LAD bypass grafting. The other patient required a re-do CABG using the free right internal thoracic artery to the circumflex branch because of occlusion at the coronary artery aneurysms after 4 years postoperatively. Meticulous preoperative diagnostic evaluations of coronary artery aneurysm may further improve the long-term outcome after surgical intervention for coronary lesions in conjunction with an aneurysm.


    • 1 May 2016
      • Vol. 69  (5) , 341-5

    [Evaluation of Portable Coagulation Analyzer in Comparison with Conventional Hospital Laboratory Instrument with Stratification of International Normalized Ratios by Therapeutic Upper Limit].

    by Konosuke Sasaki, Kiyoharu Sato, Marina Suzuki, Kiichiro Kumagai, Osamu Adachi, Yoshikatsu Saiki

    Point of care devices have been widely applied to outpatients receiving anticoagulation therapy with warfarin for monitoring prothrombin time-international normalized ratio (PT-INR) regularly. However, accuracy in measurement with the device remains undetermined when PT-INR exceeds therapeutic range. We evaluated the performance of a portable CoaguChek XS coagulation analyzer in comparison with a conventional laboratory method according to therapeutic and supra-therapeutic PT-INR values in cardiac outpatients on oral vitamin K antagonists. All participants were classified into 2 groups on the basis of PT-INR 3.0 by the laboratory method; therapeutic group less than or equal to 3.0 (n=48) and supra-therapeutic group above 3.0 (n=8). The correlation coefficients in therapeutic and in supra-therapeutic groups were r=0.82 and r=0.78, respectively (p<0.05). The difference in PT-INR between the laboratory method and the CoaguChek XS was significantly larger in supra-therapeutic group than therapeutic group (1.03±0.73 versus 0.34±0.26, p=0.042). Our study indicates that CoaguChek XS can be useful handheld coagulation analyzer to determine PT-INR rapidly; however, the device may underestimate PT-INR in supra-therapeutic range.

    • 1 February 2016
      • Vol. 69  (2) , 121-5

    [Preoperative Use of Tolvaptan in a Patient with Constrictive Pericarditis].

    by Satoshi Kawatsu, Shingo Takahara, Kou Sakatsume, Keisuke Kanda, Tomoyuki Suzuki, Shintaro Katahira, Hidenori Fujiwara, Osamu Adachi, Masatoshi Akiyama, Kiichiro Kumagai, et al.

    Tolvaptan is a new selective vasopression V2-receptor antagonist. We report our experience with a use of tolvaptan for preoperative fluid management in a patient with severe constrictive pericarditis. A 66-year-old man presented with heart failure symptoms derived from constrictive pericarditis. Chest X-ray showed right pleural effusion and chest computed tomography demonstrated severe pericardial calcification. Despite that he received optimal conventional medical treatments, his hemodynamic condition further exacerbated during hospitalization. We administered tolvaptan in an attempt to optimize preoperative fluid management. Tolvaptan was found to be remarkably effective in that regard. The body weight decreased and the heart failure symptoms improved. Pericardiectomy was performed successfully, and he recovered uneventfully.

  • Contemporary results of surgical treatment for ischemic cardiomyopathy

    by Shunsuke Kawamoto, Makoto Takahashi, Katsuhiko Oda, Kiichiro Kumagai, Masatoshi Akiyama, Osamu Adachi, Shinya Masuda, Hidenori Fujiwara, Ichiro Yoshioka, Satoshi Kawatsu, et al.

    • 1 November 2015
      • Vol. 68  (12) , 961-6

    [Early Postoperative Outcomes and Evaluation of Hemodynamics after Mitral Valve Replacement with Epic Mitral Bioprosthesis].

    by Keisuke Kanda, Teruki Kotegawa, Satoshi Kawatsu, Goro Takahashi, Ichiro Yoshioka, Hidenori Fujiwara, Osamu Adachi, Masatoshi Akiyama, Kiichiro Kumagai, Shunsuke Kawamoto, et al.

    In Guideline for Surgical and Interventional Treatment of Valvular Heart Disease, revised by Japanese Circulation Society in 2012, mitral valve replacement (MVR) with bioprosthesis is class II b recommendation for patients aged 70 years or older who have no risk factors for thromboembolism. The aim of this study was to evaluate the early postoperative surgical outcomes and the hemodynamic performance with the Epic mitral bioprosthesis. Twenty-six consecutive patients underwent MVR with Epic mitral bioprostesis at Tohoku University Hospital between April 2011 and July 2014. Twenty-five cases of 26 were evaluated their hemodynamics at discharge, and of which 19 cases of 26 were evaluated at the outpatient clinic during follow-up period. There was 1 hospital death. Long-term mortality or reoperation for any valve abnormality was not observed in the median follow-up of 23.9 ± 11.3 months. Hemodynamic date at discharge obtained by transthoracic echocardiography included mean hemodynamics of mitral valve bioprosthesis as below. Effective orifice area (EOA):2.44 ± 0.62 cm², peak mitral pressure gradient (pMPG):15.8 ± 5.3 mmHg, mean mitral pressure gradient(mMPG):7.2 ± 2.4 mmHg. Hemodynamic parameters at follow-up were found to be stable as EOA:2.25 ± 0.64 cm², pMPG:17.3 ± 5.7 mmHg, mMPG:6.2 ± 2.3 mmHg, respectively. We have attempted to elucidate our preliminary postoperative outcomes and hemodynamics after MVR with Epic mitral bioprosthesis. These in vivo hemodynamic data can serves a clinical reference.


    • 1 March 2015
      • Vol. 68  (3) , 178-83

    [Two cases of fulminant myocarditis with mesenteric ischemia].

    by Shintaro Katahira, Masatoshi Akiyama, Yasunori Tadano, Katsuhiro Hosoyama, Naoki Masaki, Keisuke Kanada, Tomoyuki Suzuki, Satoshi Kawatsu, Kiichiro Kumagai, Osamu Adachi, et al.

    Fulminant myocarditis (FM) can lead to a refractory cardiogenic shock and multiple organ failure. Mechanical circulatory support (MCS) is not infrequency required to salvage patients in a profound shock. Advanced technology in MCS such as a temporary ventricular assist device can yield improved early outcome. However, incessant mesenteric ischemia remains a challenge to be resolved even with MCS. We here-in report 2 cases of FM associated with mesenteric ischemia that was extremely difficult to diagnose and treat. Therapeutic strategy for FM with mesenteric ischemia is discussed.

  • Contralateral Pulmonary Artery Banding After Single Lobar Lung Transplantation

    by Tatsuaki Watanabe, Yoshinori Okada, Osamu Adachi, Tetsu Sado, Hiroaki Toyama, Masafumi Noda, Yasushi Hoshikawa, Hisashi Oishi, Yoji Sasahara, Yoshikatsu Saiki, et al.